KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) EPS (Basic) (2017 - 2025)

Historic EPS (Basic) for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$1.59.

  • Bionano Genomics' EPS (Basic) rose 9485.77% to -$1.59 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.68, marking a year-over-year increase of 9737.92%. This contributed to the annual value of -$88.13 for FY2024, which is 7843.05% up from last year.
  • Latest data reveals that Bionano Genomics reported EPS (Basic) of -$1.59 as of Q3 2025, which was up 9485.77% from -$1.99 recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' EPS (Basic) registered a high of -$0.04 during Q1 2021, and its lowest value of -$77.14 during Q4 2023.
  • For the 5-year period, Bionano Genomics' EPS (Basic) averaged around -$9.92, with its median value being -$1.24 (2023).
  • Per our database at Business Quant, Bionano Genomics' EPS (Basic) crashed by 566797.98% in 2023 and then surged by 9678.32% in 2025.
  • Bionano Genomics' EPS (Basic) (Quarter) stood at -$0.08 in 2021, then plummeted by 1512.92% to -$1.34 in 2022, then tumbled by 5667.98% to -$77.14 in 2023, then surged by 79.47% to -$15.83 in 2024, then soared by 89.96% to -$1.59 in 2025.
  • Its EPS (Basic) stands at -$1.59 for Q3 2025, versus -$1.99 for Q2 2025 and -$1.15 for Q1 2025.